Inogen Inc vs. Zimmer Biomet Holdings, Inc.
Zimmer Biomet Holdings, Inc. (ZBH) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| INGN | ZBH | |
|---|---|---|
| Market Cap | $136.14 million | $17.83 billion |
| Revenue (TTM) | $354.30 million | — |
| Net Income (TTM) | $-24,595,000 | — |
ZBH leads on 1 of 1 size & scale factors.
Valuation
| INGN | ZBH | |
|---|---|---|
| Price / Book | 0.78 | — |
| Price / Sales | 0.38 | — |
INGN and ZBH split the valuation factors evenly.
Profitability
| INGN | ZBH | |
|---|---|---|
| Net Margin | -6.94% | — |
| Return on Equity | -14.07% | — |
INGN and ZBH split the profitability factors evenly.
Dividend
| INGN | ZBH | |
|---|---|---|
| Dividend Yield | — | 1.03% |
INGN and ZBH split the dividend factors evenly.
Risk & Sentiment
| INGN | ZBH | |
|---|---|---|
| Short Interest | 3.20% | 1.23% |
ZBH leads on 1 of 1 risk & sentiment factors.
Dig deeper: INGN overview, INGN financials, ZBH overview, ZBH financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.